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Bare-Metal Stent and Covered Stent in the Management of Infrainguinal Arterial
Obstructive Disease: A Case-Control Study* Fabrizio Masciello, Aaron Fargion, Walter Dorigo, Sara Speziali, Elena Giacomelli, Benedetta Giannasio, Rossella Di Domenico, Carlo Pratesi. University of Florence, Florence, Italy
Objective: The objective of this study was to compare early and late results of bare-metal stents (BMSs) and covered stents (CSs) in the management of infrainguinal peripheral arterial obstructive disease in a retrospective single-center matched case-control study.
Methods: From January 2005 to December 2015, there were 455 consecutive elective endovascular interventions for infrainguinal peripheral arterial obstructive disease performed in our institution. A retrospective analysis of clinical charts of the 232 patients who had primary stenting was performed, and 169 interventions carried out with the use of a BMS were found; in the remaining 63 interventions, a CS was placed. Coarsened exact matching was performed to adjust for confounding factors in a 1:1 ratio to compare outcomes. Covariates included the history of smoking, the kind of arterial lesions on the basis of the TransAtlantic Inter-Society Consensus II classification, and the involvement of superficial femoral artery (isolated or associated with popliteal and tibial disease). Perioperative outcomes were analyzed with two tests; late results were estimated by Kaplan-Meier methods.
Results: After coarsened exact matching, 60 BMS interventions (group 1) were matched with 60 CS interventions (group 2). There were no differences between the two groups in terms of perioperative deaths, thromboses, and amputations. Follow-up was available in 119 patients, with a median duration of 24 months (range, 1-132 months). Estimated 4-year survival rates were 84.5% (standard error [SE] , 0.06) in group 1 and 76.5% (SE, 0.10) in group 2 (P ¼ .3; log-rank, 1); at the same time interval, primary patency rates were 44% (SE, 0.08) and 38% (SE, 0.10; P ¼ .1; logrank, 1.8). New endovascular procedures were necessary in 13 patients in group 1 and in 18 patients in group 2; freedom from reintervention rates at 4 years were 67% and 48.5% (P ¼ .05; log-rank, 3.8); the corresponding figures in terms of assisted primary and secondary patency were 51% and 39% (P ¼ .02; log-rank, 4.7) and 65% and 64% (P ¼ .3; log-rank, 1.6), respectively. Conversion to open repair occurred in 8 cases in group 1 and in 11 cases in group 2 (P ¼ .2; log-rank, 1.5). Limb preservation rates at 4 years were 93% in group 1 and 80% in group 2 (P ¼ .2; log-rank, 1.5).
Conclusions: BMS and CS in patients with infrainguinal arterial obstructive disease, in our experience, provided similar perioperative and follow-up results in equivalent groups of patients. There is a trend toward better late outcomes in BMS patients, requiring further analysis of longer term data.
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Use of 3.0.T High-Resolution Magnetic Resonance Imaging in the Analysis of Carotid Artery Plaques* Objective: The objective of this study was to evaluate the use of head and neck coils through a 3.0T high-resolution magnetic resonance imaging (MRI) scanner to analyze extracranial carotid artery plaque components for composition, nature, stability, wall thickness, and lumen stenosis.
Methods: Ten patients (three women and seven men) with 50% to 99% stenosis of the carotid artery due to atherosclerotic plaque formation were used in this study. They were selected from a pool of hospitalized patients at a university medical center between May and November 2017. Gadodiamide was injected to contrast the MRI scan image. The resulting image was imported into the carotid artery plaque imaging analysis software for analysis.
Results: The carotid plaques were classified into eight categories according to the American Heart Association MRI modified types. There were one type IV, one type V, two type VI, and one type VII plaques in the left carotid artery. There were two type IV and two type VI plaques and one with no plaque in the right carotid artery. A total of 8 carotid arteries with vulnerable plaques were identified of the 10 (80%), with 4 from each side. Of the remaining two patients, one had stable plaque and the other had no plaque. High-resolution MRI analysis of carotid artery plaque composition, morphology, and severity of stenosis was consistent with the intraoperative findings and specimen pathologic examinations.
Conclusions: The 3.0T high-resolution MRI scanner can accurately analyze carotid artery plaque composition and morphology and the percentage of stenosis. This technique may be used as an atraumatic nonradiation study to assess the severity and stability of carotid plaques and to predict the risks of embolic stroke.
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IP195. A Real-World Experience of Drug-Eluting and Non-Drug-Eluting Stents in Lower Extremity Peripheral Arterial Disease
Pavel Kibrik, Jesse Victory, Ronak Patel, Matthew Goldstein, Ahmad Alsheekh, Afsha Aurshina, Anil Hingorani, Enrico Ascher. Lutheran Medical Center, Brooklyn, NY Objective: Drug-eluting stents (DESs) have been promoted as an alternative to the traditional non-drug-eluting stents (nDESs) and offer the potential for improved patency rates. However, DESs are more expensive than nDESs, and results comparing these stents outside of clinical trials have been limited.
Methods: A retrospective review was performed of all inpatient infrainguinal lower extremity endovascular procedures between January 2014 and September 2016 that involved stent implantation. Procedures involving the common femoral artery, superficial femoral artery, and above-knee popliteal artery were included. The type of stent, number of stents, length of each stent, and location of stent were recorded for each procedure. End points included stent thrombosis, restenosis, reintervention, and limb loss. Postoperative arterial duplex ultrasound studies were obtained every 3 months to determine stent patency during followup visits through the end of the study period. In-stent stenosis was defined as >60% narrowing on arterial duplex ultrasound. Thrombosis was defined as in-stent occlusion, and limb loss involved only major amputations in the treated extremity. Multivariate analysis, bivariate analysis, and Student two-sample t-test were used to analyze the data.
Results: During the study period, 212 patients underwent at total of 252 procedures. Of this group, 191 procedures met inclusion criteria. The average age of the patients was 73.2 6 11.6 years, 68.6% had hypertension, and 58.1% had diabetes. The most common indication for intervention was claudication (53%), followed by critical limb ischemia (47%). There were 124 procedures that involved only nDESs (LifeStent; Bard Peripheral Vascular, Tempe, Ariz), 46 procedures that involved only DESs (Zilver; Cook Medical, Bloomington, Ind), and 21 procedures that involved both DESs and nDESs (mixed). Comparison of nDESs and DESs showed the rate of thrombosis (11.1% vs 16.7%; P ¼ .81), reintervention (13.7% vs 14.3%; P ¼ 1.0), and limb loss (9.7% vs 0.0%; P ¼ .38) to be equivalent between the groups. The 6-month primary patency rates for nDESs and DESs (41.9% vs 40.0%; P ¼ 1.0) were also equivalent. On average, the average lengths of nDESs were longer than DESs (19.2 6 14.3 cm vs 11.4 6 5.7 cm; P < .0001). Mixed nDES and DES results showed a 33% restenosis rate, 7.1% thrombosis rate, and no limb loss. The mixed stent patency rate at 6 months was 28.6%. There were no statistical differences between the nDES and DES groups with respect to sex, age, laterality, diabetes mellitus, coronary artery disease, gangrene, ulcers, hyperlipidemia, atrial fibrillation, deep venous thrombosis, claudication, ipsilateral bypass, restenosis, thrombosis, limb loss, or ipsilateral amputation. Bivariate analysis showed a higher incidence of hypertension for nDES patients (P ¼ .001).
Conclusions: In this retrospective analysis from one institution, the use of an nDES or DES did not result in a statistically significant difference in the rate of thrombosis, restenosis, ipsilateral reintervention, or ipsilateral amputation during a 2-year period in the common femoral artery, superficial femoral artery, and above-knee popliteal artery.
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Methods: A prospective observational evaluation of consecutive patients who underwent endovascular interventions for lower extremity CTOs in the OBL setting from January 2013 to November 2017 by a single surgeon was performed. In all cases, access across lesions was first attempted by an antegrade, contralateral approach. If crossing was unsuccessful, a retrograde popliteal or tibial retrograde approach was used. After successful crossing, the procedure was converted to an antegrade approach and endovascular therapy was delivered. Characteristics of the patients, CTO location, procedure performed, procedural time, costs, contrast material dose, anticoagulation dose, and radiation dose were recorded. Complications were also documented by phone on postprocedure day 1 and in a clinic visit 10 to 14 days after the procedure. Three groups were used for comparison: group 1, standard antegrade approach for femoropopliteal CTOs; group 2, standard antegrade
